Prestel, Juergen, Volkers, Peter, Mentzer, Dirk, Lehmann, Helmar C., Hartung, Hans-Peter and Keller-Stanislawski, Brigitte (2014). Risk of Guillain-Barre syndrome following pandemic influenza A (H1N1) 2009 vaccination in Germany. Pharmacoepidemiol. Drug Saf., 23 (11). S. 1192 - 1205. HOBOKEN: WILEY-BLACKWELL. ISSN 1099-1557
Full text not available from this repository.Abstract
PurposeA prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain-Barre syndrome (GBS) and its variant Fisher syndrome (FS). MethodsPotential cases of GBS/FS were reported by 351 participating hospitals throughout Germany. The self-controlled case series methodology was applied to all GBS/FS cases fulfilling the Brighton Collaboration (BC) case definition (levels 1-3 of diagnostic certainty) with symptom onset between 1 November 2009 and 30 September 2010 reported until end of December 2010. ResultsOut of 676 GBS/FS reports, in 30 cases, GBS/FS (BC levels 1-3) occurred within 150days following influenza A(H1N1) vaccination. The relative incidence of GBS/FS within the primary risk period (days 5-42 post-vaccination) compared with the control period (days 43-150 post-vaccination) was 4.65 (95%CI [2.17, 9.98]). Similar results were found when stratifying for infections within 3weeks prior to onset of GBS/FS and when excluding cases with additional seasonal influenza vaccination. The overall result of temporally adjusted analyses supported the primary finding of an increased relative incidence of GBS/FS following influenza A(H1N1) vaccination. ConclusionsThe results indicate an increased risk of GBS/FS in temporal association with pandemic influenza A(H1N1) vaccination in Germany. (c) 2014 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd.
Item Type: | Journal Article | ||||||||||||||||||||||||||||
Creators: |
|
||||||||||||||||||||||||||||
URN: | urn:nbn:de:hbz:38-424313 | ||||||||||||||||||||||||||||
DOI: | 10.1002/pds.3638 | ||||||||||||||||||||||||||||
Journal or Publication Title: | Pharmacoepidemiol. Drug Saf. | ||||||||||||||||||||||||||||
Volume: | 23 | ||||||||||||||||||||||||||||
Number: | 11 | ||||||||||||||||||||||||||||
Page Range: | S. 1192 - 1205 | ||||||||||||||||||||||||||||
Date: | 2014 | ||||||||||||||||||||||||||||
Publisher: | WILEY-BLACKWELL | ||||||||||||||||||||||||||||
Place of Publication: | HOBOKEN | ||||||||||||||||||||||||||||
ISSN: | 1099-1557 | ||||||||||||||||||||||||||||
Language: | English | ||||||||||||||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||||||||||||||
Subjects: | no entry | ||||||||||||||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/42431 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |